Case File
efta-efta01886058DOJ Data Set 10CorrespondenceEFTA Document EFTA01886058
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01886058
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Hosain Rahman
From:
Jeffrey Epstein
Sent
Sat 8/18/2012 6:48:15 PM
It appears that there is some confusion about the participants at this closing and the nature of the
shares being purchased as indicated by your comments in the attached. Both Mort and Hedosophia
are participating in this closing, so we are going to leave in place the references to multiple
purchasers. You also asked why the common stock does not have all of the rights set forth in the
investor rights agreements, such as the registration rights. The justification for the difference in price
between the preferred stock and the common stock relates, in part, to the contractual rights that the
buyers receive along with the preferred stock. Our understanding was that your client was interested
in purchasing both preferred and common, but if your client would like only to purchase Series S
Preferred Stock, I can bring that back to Aliph and see if they would be amendable to that, but then all
of the shares would be sold at the same price currently being paid for the Series 5 Preferred.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to kevacationPgmail,com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00302154
EFTA01886058
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Wire Ref
referencesRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.